GREY:SLHGF - Post by User
Comment by
SecurityNetworkon Mar 01, 2023 12:08am
261 Views
Post# 35311555
RE:STSS unknown 10 month IPO
RE:STSS unknown 10 month IPO Braden Miller, Sharps Director of Product Management, commented, “Sharps has developed a high-quality alternative solution to glass syringes through the use of inert polymers such as Cyclic Olefin Polymer (COP) and Cyclic Olefin Copolymer (COC), which offers a high-quality solution compared to traditional glass syringe systems.”
Sharps' specialized product pipeline and market strategy will include a broad range of sizes, silicon-free systems that address contamination issues for the broader healthcare market, dual chamber systems that improve drug shelf life while reducing unnecessary packaging, and customized solutions for systems that serve the growing autoinjector segment.